Abstract:Here, distinct core/ligands interface anchor structures (Au─NH─R, Au─S─R, and Au─C≡C─R, R = benzoic acid) are established in Au nanoparticles (AuNPs) to investigate the regulation of amyloid peptide conformation by precisely designed artificial nano‐chaperones. Interestingly, amino‐anchored AuNPs efficiently inhibit both Aβ and amylin fibrillization, whereas thiol‐ and alkyne‐anchored AuNPs only hinder Aβ misfolding but accelerate amylin fibrillization. Accurate construction of artificial nano‐chaperones' structure is crucial for precise regulation of protein conformational transformation, facilitating effective treatment of proteopathy. However, how the ligand‐anchors of nano‐chaperones affect the spatial conformational changes in proteins remains unclear, limiting the development of efficient nano‐chaperones. In this study, three types of gold nanoparticles (AuNPs) with different core/ligands interface anchor structures (Au─NH─R, Au─S─R, and Au─C≡C─R, R = benzoic acid) are synthesized as an ideal model to investigate the effect of interfacial anchors on Aβ and amylin fibrillization. Computational results revealed that the distinct interfacial anchors imparted diverse distributions of electrostatic potential on the nanointerface and core/ligands bond strength of AuNPs, leading to differential interactions with amyloid peptides. Experimental results demonstrated that all three types of AuNPs exhibit site‐specific inhibitory effects on Aβ40 fibrillization due to preferential binding. For amylin, amino‐anchored AuNPs demonstrate strong adsorption to multiple sites on amylin and effectively inhibit fibrillization. Conversely, thiol‐ and alkyne‐anchored AuNPs adsorb at the head region of amylin, promoting folding and fibrillization. This study not only provided molecular insights into how core/ligands interfacial anchors of nanomaterials induce spatial conformational changes in amyloid peptides but also offered guidance for precisely engineering artificial‐chaperones' nanointerfaces to regulate the conformational transformation of proteins.

High efficiency and related mechanism of Au(RC) nanoclusters on disaggregating Aβ fibrils

Engineering Nanointerfaces of Au 25 Clusters for Chaperone-Mediated Peptide Amyloidosis

Studies of the Interaction Between Aβ Peptides and Carbon Nano-Materials

Exploring The Mechanism Of Inhibition Of Au Nanoparticles On The Aggregation Of Amyloid-(16-22) Peptides At The Atom Level By All-Atom Molecular Dynamics

Highly Efficient Destruction of Amyloid-β Fibrils by Femtosecond Laser-Induced Nanoexplosion of Gold Nanorods.

Engineering Core/Ligands Interfacial Anchors of Nanoparticles for Efficiently Inhibiting Both Aβ and Amylin Fibrillization

Assembly of Nanoconjugates as New Kind Inhibitor of the Aggregation of Amyloid Peptides Associated with Alzheimer's Disease

C3N Nanodots Inhibits Aβ Peptides Aggregation Pathogenic Path in Alzheimer's Disease.

Facile synthesis of EGCG modified Au nanoparticles and their inhibitory effects on amyloid protein aggregation

Influence of Au Nanoparticles on the Aggregation of Amyloid-Β-(25–35) Peptides

Nanomaterials for Modulating the Aggregation of β-Amyloid Peptides

Nanomaterials for Modulating the Aggregation of -Amyloid Peptides

Impact of Au144 metal clusters on the structural and inhibitory mechanism of Aβ42 peptide: A theoretical approach

Size-effect of Gold Nanorods on Modulating the Kinetic Process of Amyloid-Β Aggregation

Electrostatic assembly of gold nanoparticle and metal–organic framework nanoparticles attenuates amyloid β aggregate-mediated neurotoxicity

Effects of Carbon Nanoparticles on the Aggregation of Alzheimers Beta-Amyloid Peptide

Interfacial metal atoms of metallic nano-chaperones on modulating amyloid fibrillation

A Peptide-Coated Gold Nanocluster Exhibits Unique Behavior in Protein Activity Inhibition.

Construction of a DNA Nanoassembly Based on Spatially Ordered Recognition Elements for Inhibiting β-Amyloid Aggregation

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.